Glenmark Pharma Jumps 10% After AbbVie ISB 2001 Deal

Glenmark Pharma shares soar after ISB 2001 deal with AbbVie. HSBC, Motilal Oswal raise targets to ₹2,275–₹2,430. Analysts forecast 26% upside. 🔍 Glenmark Pharma Shares Rally 10% After Landmark ISB 2001 Licensing Deal Mumbai, July 11, 2025 — Shares of…